Key result
Published retrospective data from Indian centers demonstrate that outcomes for bone and soft tissue sarcomas are comparable to Western data.
Retrospective data from major Indian centers show that outcomes for bone and soft tissue sarcomas are comparable to Western data.
Supports comparable sarcoma outcomes in Indian centers; leaves open prospective validation before practice change.
Bone sarcomas are rare tumors, approximating 0.2% of all cancers, with osteosarcoma (OGS), chondrosarcoma, and Ewing sarcoma being the most common cancers in this subset. The formation of disease management groups/clinics focused on sarcomas has resulted in better understanding and management of these uncommon tumors. Multiple large-scale retrospective data from Tata Memorial Hospital (TMH) and All India Institute of Medical Sciences have reported outcomes comparable to Western data in the field of OGS and Ewing sarcoma, with interesting prognostic factors identified for further evaluation. Soft tissue sarcomas are a rare heterogeneous group of tumors, more than 50 different tumor entities. The common subtypes identified in India include Ewing sarcoma and synovial sarcoma. Valuable work regarding brachytherapy has been done by radiation oncologists from the TMH, especially in pediatric patients.
No takes yet. Share an insight, caveat, or question.
Ramaswamy et al. (2016) conducted a review in Bone and soft tissue sarcomas. Published retrospective data from Indian centers demonstrate that outcomes for bone and soft tissue sarcomas are comparable to Western data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: